Gold M R, Miller C L, Mishell R I
Infect Immun. 1985 Sep;49(3):731-41. doi: 10.1128/iai.49.3.731-741.1985.
Soluble non-cross-linked peptidoglycan polymers are released by gram-positive bacteria when beta-lactam antibiotics are administered to humans. In this report, we show that this type of peptidoglycan can stimulate monocyte-macrophage functions that cause inflammation. Non-cross-linked peptidoglycan polymers from penicillin-treated Streptococcus faecium were purified and shown to stimulate the production of interleukin 1 by human monocytes and of colony-stimulating factors by a murine macrophage cell line. In addition, the release of plasminogen activator by human monocytes was inhibited by the soluble peptidoglycan. These in vitro results suggest that prolonged treatment with beta-lactam antibiotics, by causing the production of soluble peptidoglycan, may result in interleukin 1-mediated inflammatory reactions, excessive production of monocytes and granulocytes, and increased fibrin deposition.
当β-内酰胺类抗生素用于人体时,革兰氏阳性菌会释放出可溶性非交联肽聚糖聚合物。在本报告中,我们表明这种类型的肽聚糖可刺激引起炎症的单核细胞-巨噬细胞功能。从经青霉素处理的粪肠球菌中纯化出非交联肽聚糖聚合物,结果表明其可刺激人单核细胞产生白细胞介素1,并刺激鼠巨噬细胞系产生集落刺激因子。此外,可溶性肽聚糖可抑制人单核细胞释放纤溶酶原激活剂。这些体外实验结果表明,β-内酰胺类抗生素的长期治疗通过促使可溶性肽聚糖的产生,可能会导致白细胞介素1介导的炎症反应、单核细胞和粒细胞的过度产生以及纤维蛋白沉积增加。